We are pleased to announce that Linguamatics, an IQVIA company, and the leading Natural Language Processing (NLP) text analytics provider, has joined Accenture’s open partner ecosystem which is designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and improve patient outcomes.
The INTIENT Network for Research is an integral part of Accenture’s cloud-based informatics research platform, which has been designed to help life sciences organizations improve productivity, efficiency and innovation in drug discovery. Accenture is currently working with a select number of ISVs and organizations—including Linguamatics— to integrate their technology and content into Accenture’s research platform. This will allow life sciences companies to give their researchers access to innovative capabilities, such as Linguamatics’ innovative Natural Language Processing-based AI for high-value knowledge discovery and decision support from text. The Linguamatics award-winning platform is proven across multiple real-world use cases to deliver actionable insights that address pressing bench-to-bedside challenges with quantifiable ROI.
Linguamatics are delighted to be part of the pioneering INTIENT platform”, said Jane Reed, director of life science at Linguamatics, an IQVIA company. “Our NLP technology is used from molecule to market in pharma and healthcare organizations, to transform the data buried in unstructured text into structured data for visualization, analytics and decision-making support. Pharma companies are embracing the digital transformation revolution, and the partnership of Linguamatics with Accenture will facilitate access to NLP for research, clinical, safety and patient needs.
Linguamatics’ NLP AI capabilities will be available to life sciences companies within a common informatics framework that handles core infrastructure requirements such as data ingestion and cleansing, security and IP management, request management workflow, enterprise search, data governance, and collaboration environments.
Our collaboration with Linguamatics is an opportunity to leverage their NLP technology across the R&D life cycle in a way that has not been done before,” said Joe Donahue, managing director, Accenture. “We are excited to be working closely with the Linguamatics team and our mutual clients to help speed the discovery and launch of new medicines that improve outcomes for patients.
Contact us to learn more: